| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 122.825 | 78 |
| GSM780708 | Untreated after 4 days (C2_1) | 106.859 | 76 |
| GSM780709 | Untreated after 4 days (C3_1) | 87.8388 | 73 |
| GSM780719 | Untreated after 4 days (C1_2) | 126.812 | 78 |
| GSM780720 | Untreated after 4 days (C2_2) | 106.034 | 76 |
| GSM780721 | Untreated after 4 days (C3_2) | 101.376 | 75 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 107.589 | 76 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 125.14 | 78 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 103.537 | 76 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 99.8711 | 75 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 124.906 | 78 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 100.276 | 75 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 106.172 | 76 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 108.691 | 76 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 104.894 | 76 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 120.542 | 78 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 107.641 | 76 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 122.793 | 78 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 125.14 | 78 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 138.791 | 80 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 122.185 | 78 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 140.389 | 80 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 110.179 | 77 |